http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3104244-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
filingDate 1962-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1963-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88747c07e167cad292d59e8a12f6de62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_955c8a6560be5c64e11958234c74a9ac
publicationDate 1963-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3104244-A
titleOfInvention 17-oxygenated 2beta-fluoro-5alpha-androstan-3-ones and intermediates thereto
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3287357-A
priorityDate 1961-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3009934-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131715098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450586484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450201584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393633
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21880519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501829

Total number of triples: 25.